167 related articles for article (PubMed ID: 29566310)
1. DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.
Qin W; Xiong Y; Chen J; Huang Y; Liu T
J Cell Mol Med; 2018 Jul; 22(7):3364-3376. PubMed ID: 29566310
[TBL] [Abstract][Full Text] [Related]
2. Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
Yang T; Zhang W; Wang L; Xiao C; Wang L; Gong Y; Huang D; Guo B; Li Q; Xiang Y; Nan Y
BMC Cancer; 2018 Oct; 18(1):984. PubMed ID: 30326865
[TBL] [Abstract][Full Text] [Related]
3. [Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation].
Duan Z; Li H; Hu B; Li Y; Huang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):501-508. PubMed ID: 37340918
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
[TBL] [Abstract][Full Text] [Related]
5. [Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].
Li SJ; Zhang LS; Chai Y; Zhang YF; Zhang YM; Zeng PY; Wu CY
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):733-7. PubMed ID: 18396683
[TBL] [Abstract][Full Text] [Related]
6. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation.
Min W; Lin Y; Tang S; Yu L; Zhang H; Wan T; Luhn T; Fu H; Chen H
Circ Res; 2008 Apr; 102(7):840-8. PubMed ID: 18292600
[TBL] [Abstract][Full Text] [Related]
7. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.
Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W
J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591
[TBL] [Abstract][Full Text] [Related]
8. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
Gao Y; Hao Y; Jia Y
J BUON; 2021; 26(2):553-560. PubMed ID: 34077005
[TBL] [Abstract][Full Text] [Related]
10. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition.
Wei F; Rong XX; Xie RY; Jia LT; Wang HY; Qin YJ; Chen L; Shen HF; Lin XL; Yang J; Yang S; Hao WC; Chen Y; Xiao SJ; Zhou HR; Lin TY; Chen YS; Sun Y; Yao KT; Xiao D
Oncotarget; 2015 Oct; 6(33):35023-39. PubMed ID: 26418951
[TBL] [Abstract][Full Text] [Related]
12. Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer.
Capellero S; Erriquez J; Melano C; Mesiano G; Genta S; Pisacane A; Mittica G; Ghisoni E; Olivero M; Di Renzo MF; Aglietta M; Sangiolo D; Valabrega G
Sci Rep; 2020 Apr; 10(1):6478. PubMed ID: 32296104
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo.
Huang J; Li C; Wang Y; Lv H; Guo Y; Dai H; Wicha MS; Chang AE; Li Q
Clin Immunol; 2013 Oct; 149(1):156-68. PubMed ID: 23994769
[TBL] [Abstract][Full Text] [Related]
14. Effect of DC-CIK cell on the proliferation, apoptosis and differentiation of leukemia cells.
Qu HQ; Zhou XS; Zhou XL; Wang J
Asian Pac J Trop Med; 2014 Aug; 7(8):659-662. PubMed ID: 25149382
[TBL] [Abstract][Full Text] [Related]
15. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
16. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
[TBL] [Abstract][Full Text] [Related]
18. The effect of DC+CIK combined therapy on rat liver cancer model and its modulatory effect on immune functions.
He W; Huang Z; Zhou S; Huang L; Wang B; Zhu L; Ding Y; Yu YL; Zhang S
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):778-785. PubMed ID: 29461610
[TBL] [Abstract][Full Text] [Related]
19. Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.
Wei XC; Zhai XH; Han XR; Yang DD; Wang QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):946-51. PubMed ID: 20723306
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].
Zhou ZD; Xia DJ
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1056-60. PubMed ID: 23847957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]